Multiple Sclerosis
Advances in treatment
Clinical research is actively seeking and evaluating new treatment options for MS. It has only been about 30 years since therapies for MS started to emerge; now patients have some degree of choice when it comes to options for symptom management. Today there are many new classes of medicines being studied for all types/stages of MS, including PPMS, the most progressive form. There is a lot of interest in a newer class of therapy called a Bruton Tyrosine Kinase (BTK) Inhibitor. These inhibitors show promise for their ability to selectively eliminate troublesome cells that cause MS onset and progression. In addition, researchers are continuing to study the effect of stem cell transplants in helping the immune system ‘reset’ without problematic cell inflammation. DMTs are also being looked at for how to enhance their effectiveness.
You can get involved
Clinical research offers new opportunities for those with MS to help in the evaluation of symptom management, progression management, supportive therapy, and even digital therapies. It is easy to stay informed about clinical research for MS by signing up here to receive updates about new trials and research breakthroughs.
RECRUITING TRIALS
Latest News
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
References
-
Mayo Clinic - MS: Symptoms and Causes Multiple sclerosis - Symptoms and causes - Mayo Clinic
-
Providence Health System: Clinical trials and research bring hope to MS patients
-
MS News Today: Treatment Updates